Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Yang, Yu ^a   Li, Xiangwei ^a   Zhou, Feng ^a   Jin, Qi ^a   Gao, Lei ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHINA; CONTROL STRATEGY; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MONOTHERAPY; MULTIDRUG RESISTANT TUBERCULOSIS; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS; META ANALYSIS; PATHOPHYSIOLOGY;

CHINA; DRUG RESISTANCE, BACTERIAL; HUMANS; TUBERCULOSIS;

EID: 79958030039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020343     Document Type: Review

References (20)

1. Chiang CY, Schaaf HS, (2010) Management of drug-resistant tuberculosis. Int J Tuberc Lung Dis 14: 672-682.
2. Loddenkemper R, Hauer B, (2010) Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge. Dtsch Arztebl Int 107: 10-19.
3. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, et al. (2009) Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373: 1861-1873.
4. Caminero JA, (2010) Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 14: 382-390.
5. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, et al. (2006) Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194: 479-485.
6. Organization WH (2008) Anti-tuberculosis drug resistance in the world. Report No. 4. WHO/HTM/TB/2008.394.
7. Shen X, DeRiemer K, Yuan ZA, Shen M, Xia Z, et al. (2009) Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors. Int J Tuberc Lung Dis 13: 253-259.
8. Wang D, Yang C, Kuang T, Lei H, Meng X, et al. (2010) Prevalence of Multidrug and extensively drug-resistant tuberculosis in Beijing, china: A hospital-based retrospective study. Japanese Journal of Infectious Diseases 63: 368-371.
9. Group NTS (2002) Report on fourth national epidemiological sampling survey for tuberculosis. Chin J Tuberc Respir Dis 25: 3-7.
10. Chinese Ministry of Health (2010) National Baseline Survey of Drug-resistant Tuberculosis (2007-2008) People's Medical Publishing House.
11. Schatz A, Bugie E, Waksman SA, (2005) Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944. Clin Orthop Relat Res 437: 3-6.
12. Bammann RH, Zamarioli LA, Pinto VS, Vazquez CM, Litvoc MN, et al. (2010) High prevalence of drug-resistant tuberculosis and other mycobacteria among HIV-infected patients in Brazil: a systematic review. Mem Inst Oswaldo Cruz 105: 838-841.
13. Hu D, Liu X, Chen J, Wang Y, Wang T, et al. (2008) Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan 23: 43-55.
14. Xianyi C, Fengzeng Z, Hongjin D, Liya W, Lixia W, et al. (2002) The DOTS strategy in China: results and lessons after 10 years. Bull World Health Organ 80: 430-436.
15. Xu B, Dong HJ, Zhao Q, Bogg L, (2006) DOTS in China- removing barriers or moving barriers? Health Policy Plan 21: 365-372.
16. Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, et al. (2009) Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med 6: e1000150.
17. Jassal MS, Bishai WR, (2010) Epidemiology and challenges to the elimination of global tuberculosis. Clin Infect Dis 50 (Suppl 3): S156-164.
18. Van Deun A, Martin A, Palomino JC, (2010) Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int J Tuberc Lung Dis 14: 131-140.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
20. Gao L, Tao Y, Zhang L, Jin Q, (2010) Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 14: 15-23.